Related references
Note: Only part of the references are listed.Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
Penelope G. Foulds et al.
FASEB JOURNAL (2011)
CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease
Michael R. Sierks et al.
INTEGRATIVE BIOLOGY (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
A soluble α-synuclein construct forms a dynamic tetramer
Wei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Quantification of alpha-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies
Brit Mollenhauer et al.
BIOMARKERS IN MEDICINE (2010)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Plasma α-Synuclein in Patients with Parkinson's Disease With and Without Treatment
Raquel Duran et al.
MOVEMENT DISORDERS (2010)
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
T. Tokuda et al.
NEUROLOGY (2010)
Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
Katerina E. Paleologou et al.
BRAIN (2009)
Neuropathology of Parkinson's Disease with the R1441G Mutation in LRRK2
Jose-Felix Marti-Masso et al.
MOVEMENT DISORDERS (2009)
LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity
A. Gorostidi et al.
NEUROGENETICS (2009)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Carles Gaig et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation
Maria Teresa Giordana et al.
MOVEMENT DISORDERS (2007)
Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain
Maria C. Gonzalez-Fernandez et al.
PARKINSONISM & RELATED DISORDERS (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy
P. H. Lee et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Inhibitors of α-synuclein oligomerization and toxicity:: a future therapeutic strategy for Parkinson's disease and related disorders
Dena A. M. Amer et al.
EXPERIMENTAL BRAIN RESEARCH (2006)
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease
J Infante et al.
NEUROSCIENCE LETTERS (2006)
LRRK2 mutations in Spanish patients with Parkinson disease -: Frequency, clinical features, and incomplete penetrance
C Gaig et al.
ARCHIVES OF NEUROLOGY (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Biochemical and pathological characterization of Lrrk2
BI Giasson et al.
ANNALS OF NEUROLOGY (2006)
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease:: clinical, pathological, olfactory and functional imaging and genetic data
NL Khan et al.
BRAIN (2005)
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor -: art. no. e65
S Goldwurm et al.
JOURNAL OF MEDICAL GENETICS (2005)
Common LRRK2 mutation in idiopathic Parkinson's disease
WP Gilks et al.
LANCET (2005)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
ZK Wszolek et al.
NEUROLOGY (2004)
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
PD Mehta et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
